Daniel Woolson
Insider (Form 4 reporting owner): VP, GM-Infusion Capital CIK 1698998Name as filed: Woolson DanielIts filings on EDGARAll insiders
Measures activity, not value. Not investment advice.
Since 24 May 2018, sold $3.5M in 9 sales of ICU Medical.
Companies
Role on the latest Form 4 for each; open-market trades counted| Company | Role | Trades from | to | Purchases | Sales |
|---|---|---|---|---|---|
| ICU Medical ICUI | VP, GM-Infusion Capital | 24 May 2018 | 13 Aug 2026 | – | 9$3.5M |
What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.
Median return minus the sector fund, in percentage points; "too few trades" under 5| Open-market trades | After 3 months | After 6 months | After 12 months |
|---|---|---|---|
| After sales | +1.8 pts9 trades, 56% above the sector | -8.2 pts7 trades, 29% above the sector | -13.2 pts6 trades, 33% above the sector |
For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.
By year
Counted open-market trades, by trade date| Year | Purchases | Bought | Sales | Sold | Net |
|---|---|---|---|---|---|
| 2026 | – | – | 2 | $1.3M | -$1.3M |
| 2025 | – | – | 1 | $441K | -$441K |
| 2024 | – | – | 3 | $836K | -$836K |
| 2023 | – | – | 2 | $498K | -$498K |
| 2018 | – | – | 1 | $482K | -$482K |
Every trade
9, newest first; open-market purchases and sales only| Trade date | Company | Side | Shares | Price | Value | Planned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. | Filing |
|---|---|---|---|---|---|---|---|
| 13 Aug 2026 | ICU Medical ICUI | Sell | 5,417 | $181.33 | $982K | No | Form 4filed 13 Aug 2026 |
| 22 May 2026 | ICU Medical ICUI | Sell | 2,123 | $132.21 | $281K | No | Form 4filed 22 May 2026 |
| 25 Nov 2025 | ICU Medical ICUI | Sell | 2,897 | $152.35 | $441K | No | Form 4filed 25 Nov 2025 |
| 6 Dec 2024 | ICU Medical ICUI | Sell | 2,241 | $156.25 | $350K | No | Form 4filed 6 Dec 2024 |
| 30 Aug 2024 | ICU Medical ICUI | Sell | 2,502 | $163.22 | $408K | No | Form 4filed 30 Aug 2024 |
| 15 Mar 2024 | ICU Medical ICUI | Sell | 791 | $98.27 | $78K | No | Form 4filed 15 Mar 2024 |
| 1 Dec 2023 | ICU Medical ICUI | Sell | 1,729 | $88.03 | $152K | No | Form 4filed 1 Dec 2023 |
| 2 Feb 2023 | ICU Medical ICUI | Sell | 1,731 | $200.00 | $346K | Not stated | Form 4filed 2 Feb 2023 |
| 24 May 2018 | ICU Medical ICUI | Sell | 1,763 | $273.67 | $482K | Not stated | Form 4filed 24 May 2018 |
From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.